Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | CB-TGFBR2/NR3C1 KO NK cells |
| Trade Name | |
| Synonyms | CB-NK-TGF-betaR2-/NR3C1- cells |
| Drug Descriptions |
Limited information is currently available on CB-TGFBR2/NR3C1 KO NK cells, putative cord blood-derived allogeneic natural killer (NK) cells engineered to knockout TGFBR2 and NR3C1 (May 2026). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| CB-TGFBR2/NR3C1 KO NK cells | CB-TGFBR2/NR3C1 KO NK cells | 0 | 1 |